Publications by authors named "C Rafai"
Introduction: the National Laboratory of Clinical Biology and Public Health (NLBPH) in Bangui in the Central African Republic (CAR) carries out the vast majority of molecular screening tests for SARS-CoV-2 infection nationwide. This study aimed to show the contribution of molecular diagnosis and genomic surveillance in monitoring the evolution of longitudinal variations of the SARS-CoV-2 infection epidemic in CAR between 2020 and the end of 2022.
Methods: this is an observational study on the variations in the prevalence of detection of SARS-CoV-2 by RT-PCR at the NLCBPH from nasopharyngeal samples taken prospectively over a period of 3 years since the beginning of the COVID-19 epidemic.
Since its outbreak, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spread rapidly, causing the Coronavirus Disease 19 (COVID-19) pandemic. Even with the vaccines' administration, the virus continued to circulate due to inequal access to prevention and therapeutic measures in African countries. Information about COVID-19 in Africa has been limited and contradictory, and thus regional studies are important.
View Article and Find Full Text PDFBackground: Influenza is responsible for more than 5 million severe cases and 290,000 to 650,000 deaths every year worldwide. Developing countries account for 99% of influenza deaths in children under 5 years of age. This paper aimed to determine the dynamics of influenza viruses in African transmission areas to identify regional seasonality for appropriate decision-making and the development of regional preparedness and response strategies.
View Article and Find Full Text PDFArticle Synopsis
- A lot of money has been spent on studying the COVID-19 virus in Africa, leading to over 100,000 virus samples being analyzed to understand the spread of the disease.
- *More countries in Africa are now able to do these studies themselves, which helps them get results faster and keep a close watch on the virus.
- *To keep fighting COVID and other diseases, more funding and support for testing and research in Africa is really important for the future.
Article Synopsis
- Distinct SARS-CoV-2 lineage B.1.620 was identified in Lithuania, featuring multiple mutations in the spike protein commonly found in concerning variants like E484K and S477N.
- The study highlights the lineage's potential resistance to neutralizing antibodies and documents local instances of transmission in Europe, particularly in Lithuania.
- Evidence suggests that B.1.620 likely originated in Central Africa, supported by advanced phylogeographic methods and travel history data from infected individuals.